Nidan Labs & Healthcare Complete Financial Statements
NIDAN • Review detailed financials to uncover trends, confirm thesis & journal trades
7 Years of Data
2025 - 2019
Complete Financial Data Export
Export complete financial statements for Nidan Labs & Healthcare (NIDAN).
Downloads include all available records across all periods.
For market performance, see the
NIDAN stock price today
.
Profitability Ratios
Net Profit Margin
7.41%
2025 data
EBITDA Margin
25.93%
2025 data
Operating Margin
21.00%
2025 data
Return on Assets
2.41%
2025 data
Return on Equity
2.94%
2025 data
Balance Sheet Ratios
Current Ratio
2.20
2025 data
Debt to Equity
1.22
2025 data
Equity Ratio
81.93%
2025 data
Asset Turnover
0.33
2025 data
Year-over-Year Growth Analysis
Comparing March 2025 vs Period
Revenue Growth
-11.1%
Year-over-Year
Net Profit Growth
+50.0%
Year-over-Year
EBITDA Growth
+28.6%
Year-over-Year
Expense Growth
-25.0%
Year-over-Year
Equity Growth
+3.0%
Year-over-Year
Operating Cash Flow Growth
-66.7%
Year-over-Year
Investing Cash Flow Growth
+100.0%
Year-over-Year
Financing Cash Flow Growth
-200.0%
Year-over-Year
Income Statement
Periods
₹ Crores
| Particulars | None | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 24 | 27 | 27 | 28 | 30 | 21 | 22 | 21 |
| Expenses | 15 | 20 | 18 | 18 | 20 | 12 | 15 | 13 |
| EBITDA | 9 | 7 | 9 | 10 | 10 | 10 | 8 | 8 |
| Operating Profit Margin % | 19.00% | 21.00% | 27.00% | 28.00% | 32.00% | 44.00% | 34.00% | 38.00% |
| Depreciation | 3 | 2 | 3 | 3 | 3 | 3 | 3 | 3 |
| Interest | 3 | 2 | 2 | 2 | 3 | 4 | 4 | 5 |
| Profit Before Tax | 4 | 3 | -2 | 5 | 5 | 3 | 1 | 0 |
| Tax | 1 | 1 | 1 | 1 | 2 | 1 | 0 | 0 |
| Net Profit | 3 | 2 | -3 | 4 | 3 | 2 | 1 | 0 |
| Earnings Per Share (₹) | 2.90 | 1.42 | -2.33 | 2.55 | 2.32 | 2.33 | 0.72 | 0.23 |
Related Pages for Nidan Labs & Healthcare
Additional stock information and data for NIDAN
Balance Sheet
Years
Annual Data
₹ Crores
| Particulars | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| ASSETS | |||||||
| Total Assets | 83 | 83 | 84 | 89 | 54 | 45 | 43 |
| Current Assets | 11 | 30 | 21 | 25 | 23 | 24 | 19 |
| Fixed Assets | 16 | 18 | 21 | 21 | 20 | 20 | 23 |
| Capital Work in Progress | 0 | 0 | 0 | 4 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 67 | 65 | 63 | 64 | 34 | 25 | 20 |
| LIABILITIES | |||||||
| Total Liabilities | 83 | 83 | 84 | 89 | 54 | 45 | 43 |
| Current Liabilities | 5 | 5 | 5 | 10 | 14 | 34 | 32 |
| Non-Current Liabilities | |||||||
| SHAREHOLDERS' EQUITY | |||||||
| Total Equity | 68 | 66 | 69 | 66 | 13 | 11 | 10 |
| Share Capital | 14 | 14 | 14 | 14 | 10 | 10 | 10 |
| Reserves & Surplus | 54 | 52 | 56 | 52 | 3 | 1 | 0 |
Cash Flow Statement
Periods
₹ Crores
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 |
|---|---|---|---|---|---|---|---|
| Operating Activities | 2 | 6 | 11 | 8 | 4 | 5 | 9 |
| Investing Activities | 0 | -11 | 0 | -36 | -3 | 0 | 1 |
| Financing Activities | -3 | -1 | -10 | 29 | -1 | -2 | -6 |
| Net Cash Flow | -1 | -6 | 0 | 1 | 0 | 3 | 4 |